These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5448107)

  • 21. Diuretics and ototoxicity.
    David DS; Hitzig P
    N Engl J Med; 1971 Jun; 284(23):1328-9. PubMed ID: 5576449
    [No Abstract]   [Full Text] [Related]  

  • 22. Dropsical bullae in patients with diabetes mellitus and chronic renal failure receiving high-dose frusemide.
    Tamimi NA; al-Heresh AM; Rowland-Payne CM
    Nephrol Dial Transplant; 1995 Oct; 10(10):1943. PubMed ID: 8592614
    [No Abstract]   [Full Text] [Related]  

  • 23. High dose frusemide in acute reversible intrinsic renal failure. A preliminary communication.
    Brown CB; Ogg CS; Cameron JS; Bewick M
    Scott Med J; 1974; 19 Suppl 1():35-9. PubMed ID: 4614439
    [No Abstract]   [Full Text] [Related]  

  • 24. Experiences with high doses of furosemide in renal disease and resistant edematous states.
    Silverberg DS; Ulan RA; Baltzan MA; Baltzan RB
    Can Med Assoc J; 1970 Jul; 103(2):129-33. PubMed ID: 5430050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Furosemide].
    Fillastre JP; Apoil E; Godin N; Temperville B
    Rev Prat; 1978 Nov; 28(51):4035-6, 4039-40, passim. PubMed ID: 741189
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Tominaga N; Kida K; Inomata T; Sato N; Izumi T; Akashi YJ; Shibagaki Y
    Am J Nephrol; 2017; 46(5):417-426. PubMed ID: 29130954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Administration of massive dosages of sodium and frosemide during the last stage of chronic renal failure, with special reference to hearing disorder].
    Kondo R; Sakaue M; Sato T; Kudo K; Ariga Y
    Nihon Jinzo Gakkai Shi; 1975 Oct; 17(10):855-65. PubMed ID: 1241981
    [No Abstract]   [Full Text] [Related]  

  • 28. Diuretics in chronic renal insufficiency.
    Guédon J; Legrain M
    Adv Nephrol Necker Hosp; 1972; 2():231-5. PubMed ID: 4219688
    [No Abstract]   [Full Text] [Related]  

  • 29. [Furosemide at high doses in a girl with chronic renal failure].
    López Uriarte A; Maldonado Martínez E
    Bol Med Hosp Infant Mex; 1978; 35(3):523-7. PubMed ID: 629840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient and permanent deafness following treatment with ethacrynic acid in renal failure.
    Pillay VK; Schwartz FD; Aimi K; Kark RM
    Lancet; 1969 Jan; 1(7585):77-9. PubMed ID: 4178003
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nil nocere! Irreversible loss of hearing under kanamycin treatment in kidney insufficiency].
    Rindfleisch U; Thieler H; Spieske C
    Z Arztl Fortbild (Jena); 1974 Feb; 68(4):175-8. PubMed ID: 4838429
    [No Abstract]   [Full Text] [Related]  

  • 32. Ototoxicity of intravenous frusemide.
    Lloyd-Mostyn RH; Lord IJ
    Lancet; 1971 Nov; 2(7734):1156. PubMed ID: 4107436
    [No Abstract]   [Full Text] [Related]  

  • 33. UVA photosensitivity in photosensitive bullous disease of chronic renal failure.
    Anderson CD; Larsson L; Skogh M
    Photodermatol; 1985 Apr; 2(2):111-4. PubMed ID: 3898041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal bone histopathology in human ototoxicity due to loop diuretics.
    Arnold W; Nadol JB; Weidauer H
    Scand Audiol Suppl; 1981; 14 Suppl():201-13. PubMed ID: 6949281
    [No Abstract]   [Full Text] [Related]  

  • 35. Why diuretic treatment increases azotaemia in patients with chronic glomerulonephritis.
    Dal Canton A; Fuiano G; Conte G; Terribile M; Sabbatini M; Cianciaruso B; Andreucci VE
    Proc Eur Dial Transplant Assoc; 1983; 19():744-8. PubMed ID: 6878262
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of high doses of frusemide in patients with chronic renal failure.
    Morelli OH; Moledo LI; Alanis E; Gaston OL; Terzaghi O
    Postgrad Med J; 1971 Apr; 47():Suppl:29-35. PubMed ID: 5579767
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency].
    Heidland A; Klütsch K; Moormann A; Hennemann H
    Dtsch Med Wochenschr; 1969 Aug; 94(31):1568-74. PubMed ID: 5792635
    [No Abstract]   [Full Text] [Related]  

  • 39. [Furosemide and renal failure. II. Use of furosemide during chronic renal failure].
    Fries D; Pozet N; Zech P; Traeger J
    Lyon Med; 1971 Jun; 225(12):1231-40. PubMed ID: 5122010
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of furosemide on chronic kidney failure without dialysis].
    Ishii M
    Nihon Jinzo Gakkai Shi; 1974 May; 16(5):441-6. PubMed ID: 4478677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.